SLDB Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2023-04-27 | 2022 | Alexander Cumbo, President and Chief Executive Officer | 45,519 | 0 | 774,820 | 0 | 0 | 2,200,212 |
| 2023-04-27 | 2022 | David Tyronne Howton, Chief Administrative Officer and Secretary | 35,030 | 0 | 353,428 | 0 | 0 | 1,017,870 |
| 2023-04-27 | 2022 | Carl Morris, Chief Scientific Officer | 430,500 | 66,106 | 83,620 | 0 | 5,343 | 873,723 |
| 2023-04-27 | 2022 | Erin Powers Brennan, Former Chief Legal Officer and Secretary | 430,500 | 238,306 | 163,003 | 0 | 260,686 | 1,339,762 |
| 2023-04-27 | 2022 | Ilan Ganot, Former President and Chief Executive Officer | 532,589 | 318,285 | 306,164 | 0 | 512,418 | 2,205,508 |
| 2022-04-28 | 2021 | Erin Powers Brennan, Chief Legal Officer | 341,667 | 145,698 | 0 | 0 | 8,629 | 2,878,244 |
| 2022-04-28 | 2021 | Joel Schneider, Ph.D., Chief Operating Officer | 423,265 | 118,320 | 0 | 0 | 6,126 | 1,702,761 |
| 2022-04-28 | 2021 | Ilan Ganot, President and Chief Executive Officer | 551,100 | 187,925 | 0 | 0 | 10,004 | 3,293,809 |
| 2021-04-28 | 2019 | Ilan Ganot, President and Chief Executive Officer | 520,000 | 193,050 | 0 | 0 | 0 | 3,335,929 |
| 2021-04-28 | 2020 | Ilan Ganot, President and Chief Executive Officer | 535,000 | 294,250 | 0 | 0 | 0 | 1,481,002 |
| 2021-04-28 | 2020 | Carl Morris, Ph.D., Chief Scientific Officer | 391,000 | 156,400 | 0 | 0 | 0 | 1,224,136 |
| 2021-04-28 | 2020 | Jennifer Ziolkowski, Chief Financial Officer | 391,000 | 156,400 | 0 | 0 | 0 | 1,224,136 |
| 2020-04-28 | 2018 | Ilan Ganot, President and Chief Executive Officer | 450,000 | 247,500 | 0 | 0 | 0 | 5,983,770 |
| 2020-04-28 | 2018 | Alvaro Amorrortu, Former Chief Operating Officer | 330,000 | 132,000 | 0 | 0 | 0 | 2,842,736 |
| 2020-04-28 | 2019 | Alvaro Amorrortu, Former Chief Operating Officer | 400,000 | 108,000 | 0 | 0 | 0 | 1,523,308 |
| 2020-04-28 | 2019 | Ilan Ganot, President and Chief Executive Officer | 520,000 | 193,050 | 0 | 0 | 0 | 3,335,929 |
| 2020-04-28 | 2019 | Jorge Quiroz, M.D., Former Chief Medical Officer | 412,500 | 113,400 | 0 | 0 | 0 | 1,541,208 |
| 2019-05-03 | 2018 | Carl Morris, Ph.D. Chief Scientific Officer | 320,000 | 128,000 | 0 | 0 | 0 | 4,052,209 |
| 2019-05-03 | 2018 | Alvaro Amorrortu, Chief Operating Officer | 330,000 | 132,000 | 0 | 0 | 0 | 2,842,736 |
| 2019-05-03 | 2017 | Ilan Ganot, President and Chief Executive Officer | 400,000 | 200,000 | 0 | 0 | 0 | 600,000 |
| 2019-05-03 | 2018 | Ilan Ganot, President and Chief Executive Officer | 450,000 | 247,500 | 0 | 0 | 0 | 5,983,770 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
